Peer-influenced content. Sources you trust. No registration required. This is HCN.
NEJM Evidence
Discover how the new Clonal Hematopoiesis Risk Score can help predict myeloid neoplasm risk in CHIP/CCUS patients.
Hematology/Oncology October 17th 2023
Renal & Urology News
Discover the key predictors of PSA persistence post-prostate cancer surgery and how they can inform your treatment plans and patient discussions.
Oncology, Medical October 2nd 2023